Philip H. Coelho
Chief Executive Officer, ThermoGenesis Holdings, Inc.
Companies
- Catalyst PharmaceuticalsBoard member Oct 23, 2006 to May 5, 20231
- Ampio Pharmaceuticals, Inc.Board member Sep 27, 2011 to Jan 3, 20222
- ThermoGenesis Holdings, Inc.Chief Technology Architect Jul 31, 2007 to Jul 31, 20073
- ThermoGenesis Holdings, Inc.Board member May 15, 2006 to Jul 31, 20074
- ThermoGenesis Holdings, Inc.Chief executive officer May 15, 2006 to Apr 30, 20074
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Catalyst Pharmaceuticals CPRX204,887 shares5May 4, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 4, 2023Exercised options 50,000 shares at $0.79 of Catalyst Pharmaceuticals5
- Feb 15, 2023Exercised options 4,000 shares of Catalyst Pharmaceuticals6
- Dec 6, 2022Exercised options 1,334 shares of Catalyst Pharmaceuticals7
- Nov 23, 2022Sold 9,999 shares at $17.45 of Catalyst Pharmaceuticals8
- Nov 22, 2022Sold 20,001 shares at $17.30 of Catalyst Pharmaceuticals8
- Nov 21, 2022Sold 70,000 shares at $15.23 of Catalyst Pharmaceuticals8
- Sep 14, 2022Sold 20,000 shares at $15.75 of Catalyst Pharmaceuticals9
- Sep 13, 2022Sold 10,000 shares at $15.70 of Catalyst Pharmaceuticals9
- Aug 17, 2022Exercised options 40,000 shares at $2.53 of Catalyst Pharmaceuticals10
- Dec 3, 2021Exercised options 1,333 shares of Catalyst Pharmaceuticals11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Feb 17, 2023
- 7SEC EDGARForm 4 filed Dec 8, 2022
- 8SEC EDGARForm 4 filed Nov 23, 2022
- 9SEC EDGARForm 4 filed Sep 15, 2022
- 10SEC EDGARForm 4 filed Aug 19, 2022
- 11SEC EDGARForm 4 filed Dec 6, 2021